Photobiomodulation Therapy on Nerve Repair Using Red and... | NCT07403695

Studies
Photobiomodulation Therapy on Nerve Repair Using Red and Infra-red Diode Lasers

NCT07403695

Sponsor

mona oraby

Status

Completed

Last Update Posted

Feb 12, 2026Actual

Enrollment

30Actual

Phase

Not Applicable

Conditions

Nerve Injury

Interventions

635 wavelength
980 wavelength

Countries

Egypt

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Feb 2026

Overall Recruitment Status or Expanded Access Status

Completed

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Mar 18, 2025Actual

Primary Completion Date

Jan 18, 2026Actual

Completion Date

Jan 18, 2026Actual

First Submitted Date

Feb 5, 2026

First Submission Date that Met QC Criteria

Feb 5, 2026

First Posted Date

Feb 11, 2026Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Feb 10, 2026

Last Update Posted Date

Feb 12, 2026Actual

Oversight Module

Has Data Monitoring Committee (DMC)

Is FDA Regulated Drug

Is FDA Regulated Device

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

FDAAA801 Violation

Not provided

Description Module

Brief Summary

Peripheral nerve injury is a major concern that drastically affects the patient's quality of life. Nowadays, several treatment options are available, including medical treatments, surgical intervention, and others. However, the trending photobiomodulation effect of laser therapy is attracting many dental professionals due to its promising results on nerve rehabilitation.

The study is intended to assess and compare laser photobiomodulation using red and infra-red diode lasers on the repair of nerve injury in the maxillofacial region.

Detailed Description

Not provided

Design Module

Study Type

Interventional

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Not provided

Target Follow-Up Duration

Not provided

Phases

Not Applicable

Interventional Study Design

Allocation

Biospecimen

No data available

No data is available for this block.

Enrollment

30Actual

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
635 wavelength	Experimental		Device: 635 wavelength
980 wavelength	Active Comparator		Device: 980 wavelength

Interventions

Name	Type	Description	Arm Group Labels	Other Names
635 wavelength	Device	635 wavelength laser	635 wavelength
980 wavelength

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
visual analogue scale	from 1- 10 1 means no pain 10 means worst pain	1,2,4,8,12 weeks

Secondary Outcomes

Measure	Description	Time Frame
clinical neurosensory test	from S0 to S4 S0 means worst neurosensory function S4 full recovery for neurosensory function	2,4,8,12 weeks

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Patient aged range from 20-50 years old
Patient suffering from nerve injury in the maxillofacial region for a period of 6 months or more without improvement.

Exclusion Criteria:

1- Patient had undergone micro-neurosurgery to correct neurosensory deficit.

Accepts Healthy Volunteers

Yes

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

20 Years

Maximum Age

50 Years

Standard Ages

Adult

Study Population

Not provided

Sampling Method

Not provided

Contacts/Locations Module

Central Contacts

Not provided

Overall Officials

Name	Affiliation	Role
Mona S Oraby	Alexandria University	Principal Investigator

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Alexandria university		Alexandria			Egypt

IPD Sharing Statement Module

Plan to Share IPD

Description

Not provided

Types

Not provided

Time Frame

Not provided

Access Criteria

Not provided

URL

Not provided